Insider’s View: Deciphering Oncology Institute Inc (TOI)’s Financial Health Through Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

The price of Oncology Institute Inc (NASDAQ: TOI) closed at $2.99 in the last session, down -1.64% from day before closing price of $3.04. In other words, the price has decreased by -$1.64 from its previous closing price. On the day, 1.38 million shares were traded.

Ratios:

We take a closer look at TOI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.59 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 20.18 whereas as Long-Term Debt/Eq ratio is at 18.83.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on May 15, 2025, initiated with a Buy rating and assigned the stock a target price of $7.

On September 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $7.Guggenheim initiated its Buy rating on September 14, 2022, with a $7 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 26 ’25 when Virnich Daniel bought 22,640 shares for $1.04 per share. The transaction valued at 23,584 led to the insider holds 724,363 shares of the business.

Podnos Yale bought 9,056 shares of TOI for $9,434 on Mar 26 ’25. The Chief Medical Officer now owns 79,049 shares after completing the transaction at $1.04 per share. On Mar 26 ’25, another insider, Pacala Mark L, who serves as the Director of the company, bought 90,562 shares for $1.04 each. As a result, the insider paid 94,338 and bolstered with 224,971 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.66 while its Price-to-Book (P/B) ratio in mrq is 52.46.

Stock Price History:

Over the past 52 weeks, TOI has reached a high of $3.50, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 62.35%, while the 200-Day Moving Average is calculated to be 284.27%.

Shares Statistics:

A total of 88.93M shares are outstanding, with a floating share count of 38.24M. Insiders hold about 57.13% of the company’s shares, while institutions hold 15.22% stake in the company.

Most Popular